Arrhythmia & Electrophysiology Review最新文献_第7页

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction. 保留射血分数的心力衰竭患者房颤消融的安全性、有效性和预后获益。

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.10

Nicolas Johner, Mehdi Namdar, Dipen C Shah

{"title":"Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction.","authors":"Nicolas Johner, Mehdi Namdar, Dipen C Shah","doi":"10.15420/aer.2022.10","DOIUrl":"https://doi.org/10.15420/aer.2022.10","url":null,"abstract":"Up to 65% of patients with heart failure with preserved ejection fraction (HFpEF) develop AF during the course of the disease. This occurrence is associated with adverse outcomes, including pump failure death. Because AF and HFpEF are mutually reinforcing risk factors, sinus rhythm restoration may represent a disease-modifying intervention. While catheter ablation exhibits acceptable safety and efficacy profiles, no randomised trials have compared AF ablation with medical management in HFpEF. However, catheter ablation has been reported to result in lower natriuretic peptides, lower filling pressures, greater peak cardiac output and improved functional capacity in HFpEF. There is growing evidence that catheter ablation may reduce HFpEF severity, hospitalisation and mortality compared to medical management. Based on indirect evidence, early catheter ablation and minimally extensive atrial injury should be favoured. Hence, individualised ablation strategies stratified by stepwise substrate inducibility provide a logical basis for catheter-based rhythm control in this heterogenous population. Randomised trials are needed for definitive evidence-based guidelines.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":" ","pages":"e18"},"PeriodicalIF":3.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/4d/aer-11-e18.PMC9585645.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40454610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ventricular Dyssynchrony and Pacing-induced Cardiomyopathy in Patients with Pacemakers, the Utility of Ultra-high-frequency ECG and Other Dyssynchrony Assessment Tools. 起搏器患者的心室非同步化和起搏诱发的心肌病，超高频ECG和其他非同步化评估工具的应用。

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.01

Jan Mizner, Pavel Jurak, Hana Linkova, Radovan Smisek, Karol Curila

{"title":"Ventricular Dyssynchrony and Pacing-induced Cardiomyopathy in Patients with Pacemakers, the Utility of Ultra-high-frequency ECG and Other Dyssynchrony Assessment Tools.","authors":"Jan Mizner, Pavel Jurak, Hana Linkova, Radovan Smisek, Karol Curila","doi":"10.15420/aer.2022.01","DOIUrl":"https://doi.org/10.15420/aer.2022.01","url":null,"abstract":"The majority of patients tolerate right ventricular pacing well; however, some patients manifest signs of heart failure after pacemaker implantation and develop pacing-induced cardiomyopathy. This is a consequence of non-physiological ventricular activation bypassing the conduction system. Ventricular dyssynchrony was identified as one of the main factors responsible for pacing-induced cardiomyopathy development. Currently, methods that would allow rapid and reliable ventricular dyssynchrony assessment, ideally during the implant procedure, are lacking. Paced QRS duration is an imperfect marker of dyssynchrony, and methods based on body surface mapping, electrocardiographic imaging or echocardiography are laborious and time-consuming, and can be difficult to use during the implantation procedure. However, the ventricular activation sequence can be readily displayed from the chest leads using an ultra-high-frequency ECG. It can be performed during the implantation procedure to visualise ventricular depolarisation and resultant ventricular dyssynchrony during pacing. This information can assist the electrophysiologist in selecting a pacing location that avoids dyssynchronous ventricular activation.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":" ","pages":"e17"},"PeriodicalIF":3.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b3/2c/aer-11-e17.PMC9376832.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40713911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 6

Bridging the Gap Between Artificial Intelligence Research and Clinical Practice in Cardiovascular Science: What the Clinician Needs to Know 弥合人工智能研究与心血管科学临床实践之间的差距：临床医生需要知道的

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.07

Emily Shipley, Martha Joddrell, G. Lip, Yalin Zheng

引用次数: 1

Protecting Against Collateral Damage to Non-cardiac Structures During Endocardial Ablation for Persistent Atrial Fibrillation. 持续性心房颤动的心内膜消融对非心脏结构的附带损害。

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2021.67

Lisa Wm Leung, Zaki Akhtar, Jamal Hayat, Mark M Gallagher

引用次数: 0

Economic Evaluation of Catheter Ablation Versus Medical Therapy for the Treatment of Atrial Fibrillation from the Perspective of the UK. 英国心房颤动导管消融与药物治疗的经济评价

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2021.46

Lisa Wm Leung, Zaki Akhtar, Christos Kontogiannis, Ryan J Imhoff, Hannah Taylor, Mark M Gallagher

{"title":"Economic Evaluation of Catheter Ablation Versus Medical Therapy for the Treatment of Atrial Fibrillation from the Perspective of the UK.","authors":"Lisa Wm Leung, Zaki Akhtar, Christos Kontogiannis, Ryan J Imhoff, Hannah Taylor, Mark M Gallagher","doi":"10.15420/aer.2021.46","DOIUrl":"https://doi.org/10.15420/aer.2021.46","url":null,"abstract":"Randomised evidence supports an early rhythm control strategy as treatment for AF, and catheter ablation outperforms medical therapy in terms of effectiveness when studied as first- and second-line treatment. Despite evidence consistently showing that catheter ablation treatment is superior to medical therapy in most AF patients, only a small proportion receive ablation, in some cases after a prolonged trial of ineffective medical therapy. Health economics research in electrophysiology remains limited but is recognised as being important in influencing positive change to ensure early access to ablation services for all eligible patients. Such information has informed the updated recommendations from the recently published National Institute for Health and Care Excellence clinical guideline on the diagnosis and management of AF, but increased awareness is needed to drive real-world adoption and to ensure patients are quickly referred to specialists. In this article, economic evaluations of catheter ablation versus medical therapy are reviewed.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":" ","pages":"e13"},"PeriodicalIF":3.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/78/57/aer-11-e13.PMC9277614.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40514367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Mahaim Revisited. Mahaim Revisited .

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.12

Eduardo Back Sternick, Damian Sanchez-Quintana, Hein Jj Wellens, Robert H Anderson

{"title":"Mahaim Revisited.","authors":"Eduardo Back Sternick, Damian Sanchez-Quintana, Hein Jj Wellens, Robert H Anderson","doi":"10.15420/aer.2022.12","DOIUrl":"https://doi.org/10.15420/aer.2022.12","url":null,"abstract":"The name Ivan Mahaim is well-known to electrophysiologists. However, alternative anatomical substrates can produce the abnormal rhythms initially interpreted on the basis of the pathways he first described. These facts have prompted suggestions that Mahaim should be deprived of his eponym. It is agreed that specificity is required when describing the pathways that produce the disordered cardiac conduction, and that the identified pathways should now be described in an attitudinally appropriate fashion. The authors remain to be convinced that understanding will be enhanced simply by discarding the term 'Mahaim physiology' from the lexicon. It is fascinating to look back at the history of accessory atrioventricular junctional conduction pathways outside the normal accessory atrioventricular conduction system, and their possible role in rhythm disturbances. It took both the anatomist and the clinical arrhythmologist quite some time to understand the complex anatomical architecture and the ensuing electrophysiological properties. Over the years, the name Mahaim was often mentioned in those discussions, although these pathways were not the ones that produced the eponym. The reason for this review, therefore, is to present relevant information about the person and what followed thereafter.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":" ","pages":"e14"},"PeriodicalIF":3.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/ff/aer-11-e14.PMC9376831.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40713910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

The ATLAS Randomised Clinical Trial: What do the Superiority Results Mean for Subcutaneous ICD Therapy and Sudden Cardiac Death Prevention as a Whole? ATLAS随机临床试验:皮下ICD治疗和预防心源性猝死的总体优势结果意味着什么?

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.11.S1

Roberto Rordorf

引用次数: 3

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation. 心房颤动患者左心耳形态和功能与缺血性脑卒中风险的关系

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.08

Katarzyna Dudziñska-Szczerba, Piotr Kułakowski, Ilona Michałowska, Jakub Baran

{"title":"Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation.","authors":"Katarzyna Dudziñska-Szczerba, Piotr Kułakowski, Ilona Michałowska, Jakub Baran","doi":"10.15420/aer.2022.08","DOIUrl":"https://doi.org/10.15420/aer.2022.08","url":null,"abstract":"AF is the most common cardiac arrhythmia and has been identified as an independent risk factor for stroke. The European Society of Cardiology guidelines recommend a thromboembolic event risk assessment based on the CHA2DS2-VASc score. However, stroke also occurs in some patients with a low CHA2DS2-VASc score. Therefore, it is necessary to find new factors to improve thromboembolic risk stratification in AF patients. Over 90% of embolic strokes are caused by thrombi originating from the left atrial appendage (LAA). Thus, certain anatomical or functional parameters of the LAA could potentially be used to predict cardioembolic stroke. Studies have suggested that some of these factors, such as LAA morphology, number of LAA lobes, LAA dimensions, LAA volume, distance from the LAA ostium to the first bend of LAA, LAA orifice diameter, extent of LAA trabeculations, LAA takeoff, LAA flow velocity and LAA strain rate, are independently associated with a higher risk of stroke in a population of patients with AF and improve the performance of the CHA2DS2-VASc score. However, the results are conflicting and, so far, no new parameter has been added to the CHA2DS2-VASc score.","PeriodicalId":8412,"journal":{"name":"Arrhythmia & Electrophysiology Review","volume":" ","pages":"e09"},"PeriodicalIF":3.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ef/09/aer-11-e09.PMC9272406.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40514365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Catecholaminergic Polymorphic Ventricular Tachycardia. 儿茶酚胺能多形性室性心动过速。

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2022.09

Mohamed Abbas, Chris Miles, Elijah Behr

引用次数: 4

Arrhythmogenic Mitral Valve Prolapse. 致心律失常二尖瓣脱垂。

IF 3

Arrhythmia & Electrophysiology Review Pub Date : 2022-04-01 DOI: 10.15420/aer.2021.28

Theofanis George Korovesis, Paraskevi Koutrolou-Sotiropoulou, Demosthenes George Katritsis

引用次数: 2